Medication info
Shubastatin 5 mg (Rosuvastatin Calcium)

Shubastatin 5 mg (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
Joah Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
28 T / PTP
Approval status
Active

MFDS item code 201500672 · Approved 2015.02.10 · Insurance code 644603040

Summary

Main use
Treatment of dyslipidemia; inhibition of atherosclerosis progression; prevention of cardiovascular diseases
Who takes it
Adults · Children
Adult dose
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; for patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted for maintenance treatment. The maintenance dose is 10 milligrams once daily, and most patients are controlled with this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased to a maximum of 20 milligrams once daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but exposure was increased in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Child dose
Age 10 years to 17 years: The usual dosage range is 5 milligrams ∼ 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Adjust the dose individually for each patient according to the recommended treatment goal. Adjust the dose at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Joah Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia; inhibition of atherosclerosis progression; prevention of cardiovascular diseases

  • Hypercholesterolemia
  • hyperlipidemia
  • atherosclerosis
  • dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL-cholesterol levels
  • smoking
  • family history of premature coronary artery disease
  • risk of stroke
  • risk of myocardial infarction
  • risk of arterial revascularization
View approved original text

This medication is used as an adjunctive therapy in patients with primary hypercholesterolemia and mixed dyslipidemia when not adequately controlled by diet and exercise. It is also effective as an adjunctive therapy for patients with homozygous familial hypercholesterolemia. This drug is used to lower total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. It can also be used as an adjunct to diet in pediatric patients aged 10 to 17 years with specific criteria of heterozygous familial hypercholesterolemia. Additionally, it is used as an adjunctive treatment for patients with primary dysbetalipoproteinemia and helps reduce the risk of stroke, myocardial infarction, and revascularization procedures in middle-aged and older patients at high risk for cardiovascular disease. Based on these efficacies, it is used to improve cholesterol levels and reduce the risk of cardiovascular disease.

How to take

Adult dose

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; for patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted for maintenance treatment. The maintenance dose is 10 milligrams once daily, and most patients are controlled with this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased to a maximum of 20 milligrams once daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but exposure was increased in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Child dose

Age 10 years to 17 years: The usual dosage range is 5 milligrams ∼ 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Adjust the dose individually for each patient according to the recommended treatment goal. Adjust the dose at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, individuals allergic to this drug, those with liver problems, and patients with muscle diseases should avoid taking it. In addition, patients with severely impaired kidney function, as well as pregnant or nursing women, should not use this drug. High-dose use is prohibited in patients at high risk for muscle disease. This drug contains lactose and caution is required for patients with lactose intolerance. It is important to regularly monitor liver function and muscle status while taking this medication. Those who drink alcohol heavily or have a history of liver disease should be particularly careful. Symptoms such as muscle pain or weakness should be reported to a doctor immediately, and the drug should be discontinued if necessary. This drug may interact with other medications, so consult a doctor or pharmacist if you are taking other medications. The risk of muscle damage may increase when used in combination with certain antiviral agents, immunosuppressants, antifungals, etc. Women who could become pregnant should employ appropriate contraceptive methods, and pregnant women should not use this drug. Nursing mothers should also avoid using this medication for safety. There is no specific antidote in case of overdose, so treatment should be based on symptoms while monitoring liver function and muscle enzyme levels. While taking this medication, dizziness or headaches may occur, so caution is needed when driving or operating machinery. Finally, this drug may show higher blood concentration levels in Asians, so dosage adjustments may be necessary. Therefore, it is extremely important to take it as directed by a physician.

Side effects

Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air or moisture, and should be kept at room temperature between 1°C and 30°C. Proper storage will help maintain the drug's effectiveness and safety.

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

28 T / PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.